Recommendations on the management of fragility fracture risk in women younger than 70 years

Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology
Santiago PalaciosZion Ben-Rafael

Abstract

The risk for fragility fracture represents a problem of enormous magnitude. It is estimated that only a small fraction of women with this risk take the benefit of preventive measures. The relationship between estrogen and bone mass is well known as they are the other factors related to the risk for fracture. There are precise diagnostic methods, including a tool to diagnose the risk for fracture. Yet there continues to be an under-diagnosis, with the unrecoverable delay in instituting preventive measures. Women under the age of 70 years, being much more numerous than those older, and having risk factors, are a group in which it is essential to avoid that first fragility fracture. Today it is usual not to differentiate between the treatment and the prevention of osteoporosis since the common aim is to prevent fragility fractures. Included in this are women with osteoporosis or with low bone mass and increased risk for fracture, for whom risk factors play a primary role. There is clearly controversy over the type of treatment and its duration, especially given the possible adverse effects of long-term use. This justifies the concept of sequential treatment, even more so in women under the age of 70, since they presumably will nee...Continue Reading

References

Sep 1, 1992·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·L J MeltonB L Riggs
May 25, 1985·Lancet·R SmithB P Wordsworth
May 16, 1987·Lancet·C ChristiansenP Rødbro
Nov 1, 1994·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·J A Kanis
Jan 1, 1995·British Journal of Rheumatology·R Smith
Apr 1, 1996·Calcified Tissue International·F CosmanR Lindsay
Oct 1, 1996·Nature Medicine·D E HughesB F Boyce
Aug 18, 1997·The Journal of Experimental Medicine·T KamedaM Kumegawa
Aug 1, 1997·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·C C Glüer
Nov 14, 1997·American Journal of Public Health·J MagazinerJ R Hebel
May 18, 1999·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·P GarneroP D Delmas
Jun 3, 1999·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·O VidalC Ohlsson
Jan 14, 2000·The Journal of Clinical Endocrinology and Metabolism·R D Wasnich, P D Miller
Mar 4, 2000·QJM : Monthly Journal of the Association of Physicians·T P van StaaC Cooper
Jun 13, 2000·Archives of Pediatrics & Adolescent Medicine·G Wyshak
Sep 1, 2000·Science·G A Rodan, T J Martin
Feb 15, 2001·JAMA : the Journal of the American Medical Association·R LindsayE Seeman
Feb 15, 2001·JAMA : the Journal of the American Medical Association·UNKNOWN NIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis, and Therapy
Jan 5, 2002·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·Somnath SarkarKristine D Harper
May 23, 2002·Recent Progress in Hormone Research·S C ManolagasR L Jilka
Feb 8, 2003·The Journal of Clinical Endocrinology and Metabolism·Mara J HorwitzAndrew F Stewart
May 16, 2003·Nature·William J BoyleDavid L Lacey
Oct 2, 2003·JAMA : the Journal of the American Medical Association·Jane A CauleyUNKNOWN Women's Health Initiative Investigators
Nov 1, 2003·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·J A KanisB Jonsson
Jan 30, 2004·The New England Journal of Medicine·Pierre J MeunierJean-Yves Reginster
Jan 31, 2004·Bone·Dennis B HenriksenJens Juul Holst
Feb 19, 2004·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·Markus J SeibelAndreas Grauer
Apr 15, 2004·JAMA : the Journal of the American Medical Association·Garnet L AndersonUNKNOWN Women's Health Initiative Steering Committee
May 13, 2004·JAMA : the Journal of the American Medical Association·Emily BanksUNKNOWN Million Women Study Collaborators

❮ Previous
Next ❯

Citations

Feb 11, 2015·Climacteric : the Journal of the International Menopause Society·F H Comhaire, H T Depypere
Feb 7, 2013·Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology·Anders NedergaardClaus Christiansen
Jul 6, 2013·Maturitas·Nicolás MendozaUNKNOWN Spanish Menopause Society
Dec 3, 2014·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·H Ohta, J Solanki

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.